Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuexiao Antibacterial Gel is a topical vaginal antimicrobial formulation used for the treatment and prevention of recurrence of bacterial vaginosis (BV). It is frequently evaluated in clinical settings as an adjunct to standard antibiotic therapies, such as metronidazole, to enhance therapeutic efficacy and stabilize the vaginal microenvironment. The gel typically utilizes silver ions (nanosilver) as its active antimicrobial agent, which provides broad-spectrum activity against anaerobic pathogens by disrupting bacterial cell membranes and inhibiting essential metabolic processes. By reducing the pathogen load and facilitating the restoration of a healthy, Lactobacillus-dominant vaginal flora, Yuexiao Antibacterial Gel aims to lower the high recurrence rates associated with conventional BV treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yuexiao Antibacterial Gel.